BioNTech delivers first vaccine manufacturing facilities for Rwanda

KIGALI, March 13 (Xinhua) -- BioNTech, a German biotechnology company based in Mainz, on Monday delivered containers of the first BioNTainer- facilities equipped to manufacture a range of mRNA-based vaccines at its plant in Rwanda.

Six BioNTainers, each consisting of drug substances and formula capable of producing 50 million to 100 million vaccine doses a year were received by Rwandan Minister of Health Sabin Nsanzimana, and Sierk Poetting, the chief operating officer of BioNTech.